CIC
WVE icon

Cornercap Investment Counsel’s Wave Life Sciences WVE Stock Holding History

Cornercap Investment Counsel’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-56,051
Closed -$346K – 704
2024
Q1 		$346K Buy
+56,051
New +$281K 0.05% 505

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Cornercap Investment Counsel's WVE Position: Q2 2024 in Review

Cornercap Investment Counsel sold out of Wave Life Sciences (WVE) in Q2 2024, closing a stake of 56,051 shares — an estimated $346K sold.

Cornercap Investment Counsel first reported a position in WVE in Q1 2024 and held it in 1 quarter. The position peaked at $346K in Q1 2024. 144 funds tracked by Wall St. Rank hold WVE as of Q2 2024.

  • Cornercap Investment Counsel reported no remaining Wave Life Sciences position as of Q2 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 56,051 Wave Life Sciences shares in Q2 2024, an estimated $346K.
  • Cornercap Investment Counsel first reported a position in Wave Life Sciences in Q1 2024 and held it in 1 quarter.
  • Cornercap Investment Counsel's Wave Life Sciences position peaked at $346K in Q1 2024.
  • 144 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2024.

Based on Cornercap Investment Counsel's 13F filing for Q2 2024, filed 8 Aug 2024.